Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Inventory Average (2017 - 2025)

Historic Inventory Average for Neurocrine Biosciences (NBIX) over the last 8 years, with Q4 2025 value amounting to $69.1 million.

  • Neurocrine Biosciences' Inventory Average rose 3401.16% to $69.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $69.1 million, marking a year-over-year increase of 3401.16%. This contributed to the annual value of $63.2 million for FY2025, which is 3207.94% up from last year.
  • According to the latest figures from Q4 2025, Neurocrine Biosciences' Inventory Average is $69.1 million, which was up 3401.16% from $63.1 million recorded in Q3 2025.
  • Neurocrine Biosciences' 5-year Inventory Average high stood at $69.1 million for Q4 2025, and its period low was $26.9 million during Q3 2021.
  • Over the past 4 years, Neurocrine Biosciences' median Inventory Average value was $37.8 million (recorded in 2024), while the average stood at $42.2 million.
  • In the last 5 years, Neurocrine Biosciences' Inventory Average surged by 2242.7% in 2024 and then skyrocketed by 5430.46% in 2025.
  • Over the past 4 years, Neurocrine Biosciences' Inventory Average (Quarter) stood at $26.9 million in 2021, then rose by 24.72% to $33.6 million in 2023, then soared by 53.8% to $51.6 million in 2024, then surged by 34.01% to $69.1 million in 2025.
  • Its last three reported values are $69.1 million in Q4 2025, $63.1 million for Q3 2025, and $58.0 million during Q2 2025.